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Abstract
Background: The Leishmania spp. protozoa, the causative agents of the “neglected” tropical disease leishmaniasis,
are transmitted to mammals by sand fly vectors. Within the sand fly, parasites transform from amastigotes to procyclic
promastigotes, followed by development of virulent (metacyclic) promastigote forms. The latter are infectious to
mammalian hosts. Biochemical components localized in the parasite plasma membrane such as proteins and sterols
play a pivotal role in Leishmania pathogenesis. Leishmania spp. lack the enzymes for cholesterol synthesis, and the
dynamics of sterol acquisition and biosynthesis in parasite developmental stages are not understood. We hypothesized
that dynamic changes in sterol composition during metacyclogenesis contribute to the virulence of metacyclic
promastigotes.
Methods: Sterols were extracted from logarithmic phase or metacyclic promastigotes grown in liquid culture with or
without cholesterol, and analyzed qualitatively and quantitatively by gas chromatograph-mass spectrometry (GC-MS).
TriTrypDB was searched for identification of genes involved in Leishmania sterol biosynthetic pathways.
Results: In total nine sterols were identified. There were dynamic changes in sterols during promastigote
metacyclogenesis. Cholesterol in the culture medium affected sterol composition in different parasite stages.
There were qualitative and relative quantitative differences between the sterol content of virulent versus avirulent
parasite strains. A tentative sterol biosynthetic pathway in Leishmania spp. promastigotes was identified.
Conclusions: Significant differences in sterol composition were observed between promastigote stages, and between
parasites exposed to different extracellular cholesterol in the environment. These data lay the foundation for further
investigating the role of sterols in the pathogenesis of Leishmania spp. infections.
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Background
Leishmania spp. are the etiological agents of leishmania-
sis, a group of parasitic diseases that are endemic in 88
countries on four continents [1]. Over 20 Leishmania
spp. are collectively responsible for varied clinic manifes-
tations of human disease. Three major clinical forms in-
clude cutaneous leishmaniasis (CL), mucocutanous
leishmaniasis and visceral leishmaniasis (VL). Data com-
piled by WHO show one million cases of CL in the last
five years, and 300,000 cases of VL with 20,000 deaths
annually (http://www.who.int/leishmaniasis/en/).
The Leishmania spp. protozoa alternate between a
flagellated promastigote in the sand fly vector and an
obligate intracellular amastigote, which lacks an external
flagellum, in the mammalian host. After a sand fly vector
takes a blood meal, amastigotes transform in the sand fly
gut to procyclic promastigotes and several other inter-
mediate stages, multiply by binary fission, and eventually
develop to the metacyclic promastigotes which are infec-
tious for mammalian hosts. Metacyclic promastigotes
are inoculated by the sand fly vector during a blood meal
into a new mammalian host [2]. This process of develop-
ment from the procyclic to the metacyclic promastigotes
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is termed metacyclogenesis. Due to the technical chal-
lenges in raising sand flies in laboratory, metacyclogen-
esis is often modeled in liquid medium by culture of
promastigotes in vitro from logarithmic to stationary
growth phase, from which the metacyclic promastigotes
can be isolated by density for some Leishmania spp. to
more than 95 % purity [3]. Metacyclic promastigotes are
morphologically distinguishable from procyclic cells by
their elongated flagellum (at least double the cell body
length), and their smaller body size.
Unlike mammalian cells but similar to fungi, Leish-
mania spp. are eukaryotic kinetoplastids that
synthesize ergosterol [4]. They do not have the en-
zymes to synthesize cholesterol, although they have
detectable cholesterol that they must take up from
their external environment [5]. The sterols ergosterol
or cholesterol are essential components of plasma
membranes found in lipid rafts, membrane microdo-
mains which are also classified as detergent resistant
membranes (DRMs) due to their physicochemical
properties [6, 7]. Our prior studies using the lipid-raft
disrupting agent methyl-β-cyclodextrin (MβCD) sug-
gested that lipid rafts play a pivotal role in the viru-
lence of Leishmania spp. [8]. The anti-fungal agent
amphotericin B is widely used in patients with leish-
maniasis, especially in regions where parasites are re-
sistant to standard therapy with antimony compounds
[9, 10], or in patients co-infected with Leishmania sp.
and human immunodeficiency virus (HIV) [11].
Amphotericin B preferentially binds to ergosterol,
leading to disruption of the osmotic integrity of the
membrane in target cells [12].
Given the association between sterol content and heat
resistance of L. major [13], the objectives of current
study were (i) to identify and quantify sterols in distinct
stages of Leishmania infantum promastigotes that differ
in their virulence for a mammalian host, and (ii) to de-
termine the effects of cholesterol addition or depletion
on promastigote sterol (particularly ergosterol) content.
The data should provide a baseline for further study of
drug- or environmentally-induced changes in parasite




The Animal Care and Use Committee of the Iowa City
Veterans’ Affairs Medical Center reviewed and approved
protocols for procedures used (Protocols number
1190301 and 1190302). The animal care and use were in
accordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National
Institute of Health.
Parasites
A Brazilian strain of Leishmania infantum (previously
called L. chagasi) (MHOM/BR/00/1669) was serially
passaged in golden hamsters to maintain parasite viru-
lence. Amastigotes were isolated from infected hamster
spleens and allowed to transform to promastigotes in
HOMEM (Hemoflagellate modified Minimal Essential
Medium) with 10 % fetal calf serum (FCS) and hemin
made from commercially available ingredients as previ-
ously described [8]. Serum-free medium (SFM) was
prepared similar to HOMEM but lacking FCS and with
additional biopterin, adenosine and bovine serum albu-
min. Virulent promastigotes were used within three pas-
sages post-isolation from hamster. An avirulent strain L5
was derived from the same L. infantum isolate by serial
passage in vitro for over five years as described [14].
Cultures of virulent or avirulent promastigotes were
seeded at 1 × 106 cells/ml in HOMEM or SFM, and
allowed to grow at 26 °C to the appropriate cell density,
monitored daily by microscopic exam on a hemacytome-
ter. Metacyclic promastigotes were isolated from Day 8
stationary-phase cultures of virulent strain parasites on a
discontinuous Ficoll gradient as described [3]. Metacyclic
promastigotes could not be recovered from similar cul-
tures of avirulent promastigotes (data not shown). In some
experiments, metacyclic promastigotes were incubated in
25 mM MβCD (Sigma, St. Louis, MO) freshly prepared in
RPMI 1640 (GIBCO) at a cell density of 2 × 108 cells/ml at
room temperature for 1 h to deplete cellular sterols, and
then washed twice by centrifugation in Hanks’ balanced
salt solution (GIBCO) as described [8, 15].
Sterol isolation from promastigotes
Sterols were extracted from logarithmic phase, stationary
phase or metacyclic promastigotes with dicholoromethane
and methanol (2:1 ratio [vol/vol]; Sigma) by sequential
centrifugation according to a published protocol [16] with
some modifications as previously described [8]. Dry sterol
aliquots from 2 × 108 promastigote equivalents were main-
tained at -20 °C immediately after extraction until a single
use. Extracted sterols were saponified in 30 % KOH in
methanol and derivatized with dichloromethane and bis
(trimethylsilyl) trifluroacetamide (BSTFA) (Sigma) in 1:2
ratio following a previously-described protocol [8].
Sterol identification
Dry derivatized trimethylsilyl derivatives were analyzed
in the High Resolution Mass Spectrometry Facility at the
University of Iowa using a ThermoFinnigan Voyager sin-
gle quadruple mass spectrometer interfaced with a
Trace2000 gas chromatograph (GC). The original soft-
ware from the supplier was used for both data acquisi-
tion and processing. A DB-5ht capillary column (inner
diameter, 0.25 mm; length 30 m) (JW Scientific Inc.,
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Folsom, CA) was used. The GC temperature program
settings were 175 °C for 1 min, ramp up at 10 °C/min to
280 °C, and hold at 280 °C for 30 min. The GC inlet
temperature was set at 280 °C. The GC eluent was elec-
tronically ionized at 70 eV. The mass spectrometer was
programmed to detect a mass range of 45–700 Da.
Sterol identification was achieved by two independent
methods. First, the GC retention time of same chemical
compound is very consistent under the same experimen-
tal conditions (GC column, solvent, temperature etc.).
Therefore, known chromatograph grade cholesterol and
ergosterol standards (Sigma) were used every time to
generate spectra, used to identify the corresponding
sterol in individual samples by comparison. For
ergosterol-related compounds lacking appropriate stan-
dards, the GC retention time was used once identified
(see below). Second, the unique mass spectrum of each
GC peak was searched against the small-molecule library
(2001 version) of the National Institute of Standards and
Technology library (NIST)/EPA/NIH Mass Spectral
Library, which was purchased with the GC-MS instru-
ment. The library search program was integrated in the
Xcalibur operating software. Positive identification of a
sterol was made if its mass spectrum matched a sterol in
the library with a SI/RSI matching factor score ≥780 at a
probability score of at least 50.
Sterol quantification
Two approaches were used to quantify sterols, capable
of either relative or absolute quantification. Multiple
preliminary trials showed that either cholesterol or er-
gosterol amounts were proportionally and linearly corre-
lated with the area under its respective sterol peak on
GC spectra. Thus the area under peaks was used for
relative quantification of sterol components. For each
promastigote stage, the total amount of all sterols added
up to 100 %.
The absolute amount of cholesterol was also quanti-
fied as follows. A standard curve was generated for each
experiment using varying amounts of chromatograph-
grade cholesterol that was deuterated at six positions
([2H]cholesterol; Sigma), and varying amounts of
chromatograph-grade ergosterol (Sigma). Quality control
for each experiment was achieved by comparing multiple
standard curves run at the time of each experiment, re-
quiring a correlation factor of 0.98 or higher between
standard amounts and retention times/area under
curves. Samples and standards that did not meet quality
control were rerun. Known amounts of [2H] cholesterol
were also spiked into each sample, and samples were an-
alyzed at three levels of cell equivalents to make sure
[2H] cholesterol from at least two cell equivalents were
within the range of the standard curve. The absolute
amount of unknown cholesterol in each sample was
determined by its area relative to that of [2H] cholesterol
standards. Amounts of ergosterol and other ergosterol-
related sterols for which deuterated standards were not
available were calculated considering their relative abun-
dance compared to the absolute amount of cholesterol
in the same sample. The peak areas under curves were
used to generate the extrapolated values.
Sterol biosynthetic pathway (SBP) of Leishmania spp.
SBP genes of Trypanosoma cruzi have been identified in a
recent publication [17]. Locus identifiers of T. cruzi SBP
genes were used as gene ID to search TriTryp database
(http://tritrypdb.org/tritrypdb/, latest access date 01/30/
16), resulting in identification L. major homologues, which
were used to pull out all Leishmania spp. genes. In case of
failure, keywords of the current annotation of SBP genes
of T. cruzi were used as gene text during search. Ergosta-
7,22-dien-3β-ol was a unique case; keyword “ergosta” was
used to search Kyoto Encyclopedia of Genes and Genomes
(KEGG) website (http://www.genome.jp/kegg/, latest ac-
cess date 01/30/16) to find KEGG reactions and enzymes.
Afterwards, keyword “hydroxysteroid” was used to identify
genes in TriTryp database. Three genes were identified in
L. infantum, one of which was a conserved hypothetic
protein. The protein sequence was used to BLAST and a
putative hydroxy steroid dehydrogenase/isomerase was
identified. Accession numbers for individual genes were
identified by BLAST search.
Results
Sterol identification
We previously identified five sterols species from in-
fectious L. infantum metacyclic promastigotes cul-
tured in complete HOMEM in vitro [8]. The current
investigations included logarithmic, stationary and
metacyclic stage promastigotes in virulent (recent iso-
late) and avirulent L5 strains maintained in either
HOMEM or SFM. All five of the previously identified
sterols (cholesterol, two isomers of ergosterol with
distinct GC retention time, ergosta-7,22-dien-3β-ol,
and stigmasta-7,24(28)-dien-3β-ol) were identified in
addition to four new sterols (ergostatetraenol, an add-
itional isomer of ergosta-7,22-dien-3β-ol, zymosterol
and lanosterol; Table 1; Fig. 1).
Dynamic changes in sterols during promastigote
metacyclogenesis
Discovery of sterols that are differentially represented in
metacyclic versus less virulent promastigotes may pro-
vide clues to the differentiation and pathogenicity of the
metacyclic promastigotes. Therefore sterols were iso-
lated from a recent isolate of virulent L. infantum pro-
mastigotes cultured in HOMEM with 10 % FCS in vitro,
in either logarithmic (day 3 to 4 of culture) or metacyclic
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stage. Metacyclic promastigotes were isolated from day 8
stationary-phase promastigotes.
The dominant sterols in logarithmic-phase promasti-
gotes were ergosterols. Ergosterol-I and ergosterol-II,
two isomers with distinct retention times on the GC col-
umn, accounted for 30.92 % and 39.13 % of total sterols,
respectively (Fig. 2a). The third most abundant sterol
was cholesterol, accounting for 14.60 % of total sterols.
In contrast, in stationary-phase promastigotes the two
ergosterol isomers accounted for only 19.09 % and
21.74 %, respectively of total sterols, whereas cholesterol
was the most abundant and constituted 27.77 % of total
sterols (Fig. 2a). Metacyclic promastigotes were different
from both; the two ergosterols accounted for only
8.94 % and 5.18 %, respectively, of total metacyclic pro-
mastigotes sterols. The two most abundant sterols in
metacyclics were ergosta-7,22-dien–3β-ol-II and choles-
terol, accounting for 37.90 % and 29.11 % of total sterols,
respectively. The differences in sterols among the vari-
ous promastigote stages were statistically significant
(Fig. 2a), suggesting a stage-specific expression of vari-
ous sterols in virulent L. infantum promastigotes.
We also analyzed sterols of a L. infantum avirulent L5
strain, which was derived by continuous culturing in vitro
of a wild-type virulent strain for over 5 years as previously
described [14]. As previously shown L5 appeared to
undergo no metacyclogenesis, since almost no metacyclic
promastigotes were recovered from stationary-phase L5
promastigotes (< 0.1 % recovery rate, compared to 13.4 %
in the wild-type strain) [3]. In this strain, the most abun-
dant sterols in both log and stationary phase promasti-
gotes were ergosterol-II, accounting for 39.93 % and
39.28 % of total sterols, respectively (Fig. 2b). In log phase
promastigotes the next two most abundant sterols were
ergosterol-I (28.68 %) and cholesterol (16.68 %). In
stationary cells, they were cholesterol (33.69 %) and
ergosterol-I (18.99 %) (Fig. 2b). The difference between
these two stages were statistically significant (Fig. 2b), indi-
cating there is stage-specific variation in sterols in aviru-
lent L. infantum, even in the absence of the capacity to
undergo metacyclogenesis.
Cholesterol in the culture medium affected sterol
composition in L. infantum promastigotes
Trypanosomatid protozoa do not have the enzymes to
synthesize cholesterol, and it has been shown that the
bloodstream form of T. brucei can take up cholesterol
from its environment [4]. As such, we hypothesized that
the Leishmania culture medium might be an important
determinant of the protozoan sterol composition. Pro-
mastigotes were cultured in parallel in either HOMEM
supplemented with 10 % FCS, thus bathing the parasites
in an exogenous source of cholesterol, or in a defined
SFM that was similar to HOMEM but lacked serum
(and thus lacked cholesterol). Sterols from stationary
growth-phase promastigotes incubated in these media
were compared. In virulent strain L. infantum, choles-
terol accounted for 27.77 % and 3.69 % of total sterols in
parasites grown in the serum-containing or serum-free
media, respectively (P < 0.001, Fig. 2c). The proportions
were 33.69 % and 1.14 % in avirulent L5 strain L. infan-
tum, respectively (P < 0.0001, Fig. 2b). These data veri-
fied that cholesterol was reduced to minimal amounts in
promastigotes incubated in a cholesterol-low environ-
ment, while other compounds were not as dramatically
altered. Whether these were compensatory changes or
merely changes in proportions required us to study the
absolute cholesterol amounts, below.
Sterols in virulent versus avirulent strain of L. infantum
Qualitative and quantitative differences in sterol com-
position between virulent and avirulent Leishmania spp.
have not been reported, nor has it been determined
whether virulence affects the ability of promastigotes to
adsorb cholesterol from their environment. We therefore
compared the relative amounts of each sterol compo-
nent in log or stationary phase virulent or avirulent
strains of L. infantum, cultured in either cholesterol-
containing HOMEM or in cholesterol-free SFM. The re-
sults are summarized in Table 2. Several differences were
observed. First, both virulent and avirulent L. infantum
were able to adsorb cholesterol from the environment.
Second, the amount of ergosterol-I in virulent L. infan-
tum grown in SFM was proportionally greater than the
avirulent L5 strain, with the difference made up by a
relative decrease in ergosterol-II. Ergosterol-II was also
decreased in virulent stationary parasites incubated in
HOMEM, but in this case it was compensated by a sig-
nificant increase in ergosta-7,22-dien-3β-ol compared to
Table 1 Sterols identified by gas chromatograph-mass
spectrometry (GC-MS) in promastigotes of Leishmania





Ergosterol - I II 1.069
Ergosta-7,22-dien-3β-ol - I New 1.078
Ergostatetraenol New 1.086
Ergosterol - II III 1.115
Ergosta-7,22-dien-3β-ol - II VI 1.131
Lanosterol New 1.157
Stigmasta-7,24(28)-dien-3β-ol V 1.229
aI-V were identified previously [8]. New indicates sterols identified in the
current study
bRelative retention time (RRt) to cholesterol on GC, which is the ratio of
retention time of each sterol to that of cholesterol
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Fig. 1 (See legend on next page.)
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the avirulent L5 strain in either log or stationary growth
phase (Table 2). These data demonstrate a difference in
sterol synthesis between virulent and avirulent strains
that extends beyond the ability to adsorb cholesterol
from the external environment.
Dynamic changes in absolute amounts of sterols during
promastigote metacyclogenesis
The above proportional differences in sterol content
cannot reveal whether some parasite forms are relatively
depleted of membrane sterols. We therefore measured
absolute sterol amounts either directly or indirectly as
described above. Surprisingly, stationary-phase promasti-
gotes cultured in HOMEM had roughly two times the
total sterol content compared to purified metacyclic pro-
mastigotes. The most dramatic differences were in chol-
esterol, and ergosterol-I and -II (Table 3). Depletion of
sterols in the metacyclic promastigotes by MβCD treat-
ment validated the measurements of sterols in other
forms.
Absolute sterol content in avirulent or virulent parasites
in different culture media
Absolute quantification revealed that total sterols were
higher in either virulent or avirulent L. infantum strains
when cultured in a cholesterol-containing medium
(HOMEM) than in medium without cholesterol (SFM).
Furthermore, virulent parasites contained more total ste-
rols than the avirulent L5 strain grown in either
medium. In virulent strain L. infantum promastigotes,
the amount of cholesterol in stationary phase promasti-
gotes was about 25 times higher when cultured in
HOMEM (448.3 ng) than in SFM (18.0 ng). Nevertheless
the cells in SFM synthesized more ergosterol-I and -II,
i.e., 1001.8 ng in SFM compared to 734.6 ng in the
HOMEM (Additional file 1: Table S1). In avirulent L5
strain L. infantum, the cholesterol amount was also
many-fold higher when promastigotes were cultured in
HOMEM than in SFM. Interestingly and in contrast to
the virulent strain, L5 promastigotes in SFM appeared
not to have synthesized more ergosterols despite choles-
terol depletion (Additional file 1: Table S1).
Leishmania spp. sterol biosynthetic pathway (SBP)
Based on the Trypanosoma cruzi genome, homologous
SBP genes of L. infantum were identified for the
multiple reactions from farnesyl diphosphate to ergos-
terol. Furthermore, an enzyme was identified for the re-
action between ergosterol and ergosta-7,22-dien-3β-ol.
Consequently all identified sterols reported in the
current study were fitted in an SBP as shown in Fig. 3.
One exception was stigmasta-7,24(28)-dien-3β-ol. No
entry was found in either the TriTryp or the KEGG da-
tabases using keyword “stigmasta”. Corresponding genes
and accession numbers of other Leishmania spp., includ-
ing but are not limited to L. donovani, L. major, L. brazi-
liensis, L. mexicana and L. panamensis, were also
identified (Additional file 2: Table S2).
Discussion
The genomes of the trypanosomatid protozoans, includ-
ing Trypanosoma spp. and Leishmania spp., have genes
encoding enzymes that catalyze the biosynthesis of er-
gosterol but not cholesterol [18–21]. This characteristic
is more similar to fungi than other eukaryotes including
mammals [22]. Consequently, amphotericin B, which se-
lectively binds to ergosterol leading to disruption of the
osmotic integrity of the membrane in target cells [12], is
a powerful agent used for treatment of leishmaniasis and
fungal infections of medical and veterinary importance.
Amphotericin B is widely used as a first-line anti-
leishmanial agent in patients from India where
antimony-resistant strains of Leishmania spp. are the
rule, or in the case of HIV - Leishmania spp. co-
infections [10, 23].
Goad and colleagues (1984) identified major sterols of
promastigotes of L. tropica, L. donovani, L. mexicana and
L. major by GC-MS[5], and Xu and colleagues recently
quantified sterols of L. major [13]. In keeping with the effi-
cacy of treatment modalities, transient treatment with mil-
tefosine, the first orally active anti-leishmanial drug
effective in VL, significantly affects sterol content of L.
donovani promastigotes. In one study, cholesterol and
cholesta-5,7,24-trien-3β-ol were 2× and 32× higher, re-
spectively, whereas ergosta-7,24(28)-dien-3β-ol and
ergosta-5,7,24(28)-trien-3β-ol were 15× and 5 × lower, re-
spectively, in miltefosine treated than untreated promasti-
gotes [24]. Similarly, other anti-leishmanial agents such as
chalcone and azasterols changed sterol profiles in L. ama-
zonensis [25, 26]. Drug resistance is associated with signifi-
cantly altered sterol profiles (e.g. atovaquone-resistant L.
infantum [16], miltefosine-resistant L. donovani [27]).
(See figure on previous page.)
Fig. 1 Representative gas chromatography spectra (GC) of total sterols of Leishmania infantum virulent and avirulent strains cultured in complete
HOMEM or serum-free medium (SFM). Shaded peaks were identified as sterols with relative retention time to cholesterol as marked. 1.000-Cholesterol;
1.030-Zymosterol; 1.069-Ergosterol – I; 1.078-Ergosta-7,22-dien-3β-ol – I; 1.086-Ergostatetraenol; 1.115-Ergosterol – II; 1.131-Ergosta-7,22-dien-3β-ol – II;
1.157-Lanosterol; and 1.229-Stigmasta-7,24(28)-dien-3β-ol. a Stationary promastigotes of virulent strain cultured in HOMEM. b Stationary promastigotes
of avirulent L5 strain cultured in HOMEM. c Stationary promastigotes of virulent strain cultured in SFM. The GC spectra of metacyclic promastigotes had
been previously published [8]
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Despite their inability to synthesize the compound,
Trypanosomatids have ample cholesterol when mea-
sured [28], leading to questions about the relative im-
portance of different sterols in pathogenesis. Herein we
describe qualitative and quantitative analyses of sterol
content in L. infantum promastigotes, the causative
agent of VL. Our data suggest there is substantial ad-
sorption of cholesterol from the parasite’s external envir-
onment, complicating interpretation of sterol content.
To the best of our knowledge, this is the first report of
the absolute amounts of sterols in parasites that differ in
virulence and in developmental stage. We also make the
unique observation that the sterol content is dramatic-
ally altered in different environmental media.
Sterols are identified by their relative retention time
(RRt) observing their mass spectrum peak on gas chro-
matography. Goad and colleagues (1984) measured ste-
rols in logarithmic-phase promastigotes of several
Leishmania spp., reporting only trace amounts of chol-
esterol in cells cultured in lipid-free medium [5].
Ergosta-5,7,24(28)-trien-3β-ol was the dominant sterol
among various species of Leishmania spp., ranging from
about 60 % in L. major, 70 % in L. tropica, L. mexicana
and L. donovani and up to 90 % in L. amazonensis and
L. pifanoi [5]. Consistent with that report, we observed
that cholesterol comprised less than 4 % of total sterols
in promastigotes cultured in cholesterol-free SFM, with
a much higher representation of ergosterol. This was in
contrast to much higher percentages of cholesterol in
promastigotes cultured in HOMEM containing FCS as a
cholesterol source, confirming the ability of parasites in
either growth stage to adsorb cholesterol from their ex-
ternal medium. In addition we detected eight sterols
other than cholesterol, all presumptively precursors or
derivatives of ergosterol (Fig. 3) (discussed below). These
observations are consistent with the conclusion that er-
gosterol is the major sterol synthesized by Leishmania
spp. with or without cholesterol in the external
environment.
Less abundant sterols included ergosta-7,22-dien-3β-ol
(20.7 %), stigmasta-7-24(28)-dien-3β-ol, ergostatetraenol,
zymosterol and lanosterol, all less than 4 %. The last
three had been found to be precursors of ergosterol in
Leishmania spp., T. brucei, T. cruzi and the yeast
Fig. 2 Sterol amount in percentage (%) among logarithmic,
stationary and metacyclic promastigotes of L. infantum virulent or
avirulent L5 strain grown in complete HOMEM or serum-free medium
(SFM). LOG: logarithmic phase promastigotes; STAT: stationary phase
promastigotes; META: metacyclic promastigotes. For each developmental
stage, all sterols were added up to 100 %. a Virulent strain grown in
HOMEM. b Avirulent L5 strain grown in HOMEM or SFM. c Stationary
phase promastigotes of virulent strain cultured in HOMEM or SFM.
*P< 0.05; **P< 0.01; ***P< 0.001; ****P< 0.0001
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Saccharomyces cerevisiae [4, 17, 29, 30]. Ergosta-7,22-
dien-3β-ol has been previously detected in L. donovani
and L. amazonensis [24, 26, 27] as well as in S. cerevisiae
yeast and Ganoderma pfeifferi fungus [31, 32]. How it
fits to the SBP has not been established. We identified
an enzyme, hydroxysteroid dehydrogenase/isomerase
(Accession number: XP_001464825.1) in the Leishmania
genome, which could potentially catalyze a reaction link-
ing ergosta-7,22-dien-3β-ol to ergosterol (Fig. 3).
Stigmasta-7–24(28)-dien-3β-ol has been found in the
fungus Gymnosporangium juniper [33]; ergostatetraenol
in Candida albicans and S. cerevisiae [34, 35]; ianosterol
in the woody plant pathogen Eutypa lata [36]; and
zymosterol in S. cerevisiae [35].
Further discussion of stigmasta-7–24(28)-dien-3β-ol is
warranted. This sterol has not been found in T. brucei
[29] although it is often found in fungi and plants. This
observation might have several explanations. First, the
validity of stigmasta-7–24(28)-dien-3β-ol identification
must be considered. The GC-MS peaks favorably argues
for its identification, which is shown in the Additional
file 3: Fig. S1. Secondly, this sterol might be taken up by
Leishmania spp. promastigote from FCS, where it could
be present in trace amounts. Our data do not support
such a scenario. As showed in Table 2 promastigotes
cultured in SFM had higher levels of this sterol com-
pared to the cells derived from HOMEM. Thirdly, bio-
synthetic enzymes for this sterol might be unique to
Leishmania spp. Stigmastanol is formed from either β-
sitosterol by reduction, or through hydrogenation of
stigmasterol.
Stigmasterol and sitosterol are phytosterols derived
from mevalonate biosynthetic pathways. Isoprenoid
synthesis is controlled by 3-hydroxy-3-methylglutaryl-
Table 2 Relative sterol content of a recently isolated virulent (vir) strain compared to an avirulent (L5) strain of Leishmania infantum
Parasite-growth phase L5-LOG (n = 2) Vir-LOG (n = 3) L5-STAT (n = 5) Vir-STAT (n = 11) L5-STAT (n = 3) Vir-STAT (n = 3)
Growth Medium HOMEM SFM
Sterol:
Cholesterol 16.68 (3.70) 14.60 (0.38) 33.69 (5.25) 27.77 (7.94) 1.14 (0.13) 3.69 (4.28)
Zymosterol 0.00 (0.00) 0.00 (0.00) 0.27 (0.38) 0.71 (2.17) 0.72 (0.63) 2.52 (2.25)
Ergosterol -I 28.68 (6.48) 30.92 (3.73) 18.99 (3.85) 19.09 (7.59) 22.96 (3.09) 34.70* (5.98)
Ergosta-7,22-dien-3β-ol - I 5.62 (6.48) 4.76 (3.74) 2.29 (1.58) 5.50 (4.64) 2.16 (1.94) 1.64 (1.33)
Ergostatetraenol 3.27 (4.62) 3.38 (3.57) 1.92 (1.72) 0.72 (1.25) 1.97 (1.80) 3.39 (2.39)
Ergosterol -II 39.93 (2.62) 39.13 (1.37) 39.28 (5.81) 21.74** (11.33) 50.17 (5.33) 31.33* (8.09)
Ergosta-7,22-dien-3β-ol- II 1.71 (0.04) 6.58* (1.20) 0.84 (0.66) 20.66*** (9.43) 12.69 (9.50) 12.56 (7.28)
Lanosterol 0.00 (0.00) 0.00 (0.00) 0.16 (0.36) 0.15 (0.35) 1.14 (1.07) 0.58 (1.00)
Stigmasta-7,24(28)-dien-3β-ol 4.10 (5.80) 0.63 (0.32) 2.50 (3.44) 3.65 (1.88) 4.77 (2.50) 9.60 (5.17)
Data show the average (standard deviation) percentages of each sterol relative to the total amount of sterols in each cell type, set at 100 %. Sterols were
identified and quantified by gas chromatograph-mass spectrometry. L. infantum virulent (vir) or avirulent L5 promastigotes were cultured in either HOMEM or
serum free medium (SFM) and harvested for sterol analyses in logarithmic (LOG) or stationary (STAT) growth phases
*P < 0.05; **P < 0.01; ***P < 0.001
Table 3 Absolute amounts of sterols of stationary and metacyclic promastigotes of a virulent strain of Leishmania infantum,
incubated in the absence or presence of MβCDa
Sterol Stationary (n = 6) Metacyclic (n = 6) MβCD-metacyclic (n = 6)
Cholesterol 448.3 (249.2) 248.9 (120.8) 89.0 (40.6)*
Ergosterol -I 331.0 (290.5) 68.4 (13.1) 40.3 (22.3)*
Zymosterol 44.2 (108.2) 0.0 (0.0) 0.0 (0.0)
Ergosta-7,22-dien-3β-ol - I 81.8 (40.6) 100.6 (45.8) 49.3 (17.2)*
Ergostatetraenol 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
Ergosterol - II 403.6 (437.7) 35.7 (33.4) 11.5 (9.3)
Ergosta-7,22-dien-3β-ol - II 387.8 (282.1) 318.9 (137.8) 81.8 (37.3)**
Lanosterol 6.4 (15.7) 0.0 (0.0) 0.0 (0.0)
Stigmasta-7,24(28)-dien-3β-ol 62.8 (63.6) 37.8 (19.4) 17.5 (8.6)*
Total 1766.0 (1307.8) 810.2 (239.2) 289.5 (120.7)**
aNumbers indicate the mean (SD) absolute concentrations of sterols (ng/107 cells). Metacyclic promastigotes were isolated from stationary phase promastigotes as
previously described [3]. An aliquot of the metacyclic cells were treated with 25 mM MβCD
*P < 0.05; **P < 0.01 between metacyclic and MβCD-treated metacyclic promastigotes
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CoA reductase (HMG-CoA reductase). The first com-
mitted step toward phytosterol biosynthesis is SMT1
(C-24 sterol methyl transferase), and the subsequent
action of SMT2, which catalyzes a methyl transfer to
methylene lophenol, directs the product toward sitos-
terol and stigmasterol biosynthesis. The annotated ge-
nomes of both L. infantum and T. brucei include
genes predicted to encode a HMG-CoA reductase
(LinJ.30.3230 and Tb927.6.4540). Two genes for a
sterol 24-C methyl transferase are found in the L. infan-
tum JPCM5 genome: LinJ.36.2510 and LinJ.36.2520, as is a
sterol C-24 reductase (LinJ.33.0730) and several other
(C-8, C-14) sterol reductases. The T. brucei genome also
encodes two sterol 24-C-methyl transferases (TB11.v5.0496,
Tb927.10.6950) and only one annotated (C-14) sterol
reductase. Whether the enzymes of L. infantum participate
in stigmastanol synthesis, and whether the additional sterol
reductase genes present in L. infantum over T. brucei are
influential in the differential recognition of stigmastanol
only in L. infantum, cannot be determined without further
experimental evidence. ([37], trytrypdb.org).
This would not be the first discovery of a pathway in
Leishmania spp. that is more closely related to fungal
metabolic pathways than those of Trypanosoma brucei.
Indeed, T. brucei take in iron primarily through a trans-
ferrin receptor, whereas the Leishmania species use a
two-step surface ferric iron reductase (Fe3+→ Fe2+)/fer-
rous iron transferase [38–40].
Calculations of absolute amounts of each sterol
allowed us to assess (1) whether the total sterol content
Fig. 3 Sterol biosynthetic pathway of Leishmania spp. Sterols identified in the current study are labeled in red. Enzymes involved in each step of
reaction are: 1, Lanosterol 14-α-demethylase; 2, C-14 sterol reductase; 3, C-5 sterol desaturase; 4, NAD(p)-dependent steroid dehydrogenase-like
protein; 5 & 6, unknown; 7, Sterol 24-c-methyltransferase; 8, C-8 sterol isomerase-like protein; 9, Lathosterol oxidase-like protein; 10, Cytochrome
p450-like protein; 11, Sterol C-24 reductase; 12, Hydroxysteroid dehydrogenase/isomerase
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is associated with parasite virulence, and (2) whether
adsorbed cholesterol inhibits ergosterol synthesis. Rele-
vant to the first question, the total amount of sterols in
1 × 107 stationary-phase promastigotes was 1,766.0 ng,
roughly double the amount in purified metacyclic pro-
mastigotes from the same culture (810.2 ng, Table 3).
The difference was mainly accounted for by a reduction
in ergosterol I and II, with a lowering of adsorbed chol-
esterol as a second contributory change. L. infantum
stationary-phase promastigotes contain 41.4 % metacyc-
lic cells [3], so the remaining non-metacyclic promasti-
gotes must have accounted for the differences. This
difference may be partially explained by a smaller body
size of the metacyclic promastigotes observed in both
flow cytometry [41, 42] and microscopy [3, 41, 43–46],
although this cannot be the full explanation since there
were proportional differences between sterols in the
populations, and because most sterols are located at the
cellular membrane [47, 48]. Nevertheless, the significant
difference in proportions suggest differences in ergos-
terol synthesis may contribute. Metabolic changes dur-
ing metacyclogenesis could in part be favored by the
absence of purine, or by an acidic environment [49–51].
It is possible that other environmental conditions such
as environmental cholesterol/sterol concentrations also
favor metacyclogenesis.
Cholesterol and ergosterol are integral components of
plasma membrane micro-domains called lipid rafts, also
known as detergent-resistant membrane (DRMs) [52].
MβCD specifically chelates and depletes sterols from
lipid rafts. In the current study we confirmed our earlier
report that MβCD treatment of metacyclic promasti-
gotes reduced the total amount of cellular sterols by two
thirds. We previously reported that lipid-raft depleted
metacyclic promastigotes exhibit increased sensitivity to
complement medicated lysis in vitro and reduced infect-
ivity for mice in vivo [8].
Leishmania spp. are inoculated by the sand fly into
mammalian tissue in a pool of blood, a relatively choles-
terol rich environment. Our observations raise the possi-
bility that suspension in such an environment might
alter the membrane sterol content of the inoculated
parasite. Host cholesterol levels affect the outcomes of
Leishmania spp. infections. It has been reported that
high circulating lipid levels offer protection against L.
donovani infection in a mouse model where mice were
either provided a high-cholesterol (atherogenic) diet or
underwent statin treatment [53]. Similarly, patients with
active VL had a lower level of total cholesterols during
acute disease than four months after VL resolution in
the same patients, and lower cholesterol than healthy
volunteer controls [54]. Whether transient exposure to
this environment at the initial stage of infection affects
the virulence of promastigotes is a matter of speculation.
From the current work we can conclude that the sterol
content of Leishmania promastigotes is dynamic and re-
sponds not only to environmental conditions, but also
the developmental changes that occur during metacyclo-
genesis. These changes seem to be a result of both ad-
sorption of cholesterol from the environment, and likely
also ergosterol synthesis by the Leishmania spp. para-
sites. The interaction between sterol content and para-
site virulence is a yet evolving story.
Conclusions
Leishmaniasis causes 20,000 annual deaths and is a threat
to 5 % of the populations of four continents worldwide. Its
causative pathogens include more than 20 species of
protozoan parasites in the genus of Leishmania, and there
is an association between parasite species and clinical out-
comes. The pathogenic mechanisms used by the parasite
are incompletely understood, and a better understanding
could speed both vaccine development and new drug dis-
covery. We hypothesized that dynamic changes in sterol
composition during parasite development contribute to
development of virulent forms of the parasite that are the
most infectious for mammalian hosts such as humans.
Qualitative and quantitative measures of sterols using gas
chromatograph-mass spectrometry enabled us to contrast
sterols in infectious versus non-infectious parasite forms.
Our data clearly showed a unique profile of sterols in the
infectious parasites, and revealed that external environ-
ment is a major determinate of cellular sterol content.
These discoveries warrant further investigation of roles of
sterols in Leishmania spp. pathogenesis.
Additional files
Additional file 1: Table S1. Effect of different culture media on
absolute sterol content of stationary-phase promastigotes of a virulent
strain compared to an avirulent strain of Leishmania infantum+.
(DOCX 13 kb)
Additional file 2: Table S2. Homologous genes of Leishmania spp.
sterol biosynthetic pathway (SBP). Trypanosoma cruzi SBP genes were
used as gene ID during database search except those marked with an “*”,
in which keyword search was used. Blank cells indicate data not available.
(XLSX 17 kb)
Additional file 3: Figure S1. Identification of stigmasta-7,24(28)-
dien-3β-ol by GC-MS. A: GC-MS peaks of the compound at Relative
retention time (RRt) of 1.229. B: Peaks of CAS #481-19-6, stigmasta-
7,24(28)-dien-3β-ol. C: Comparison of the peaks in A and B and
relative amount for each peak is shown. (PPTX 100 kb)
Abbreviations
CL: cutaneous leishmaniasis; DRM: detergent resistant membranes; FCS: fetal
calf serum; GC-MS: gas chromatograph-mass spectrometry; KEGG: Kyoto
Encyclopedia of Genes and Genomes; MβCD: methyl-β-cyclodextrin;
SFM: serum free medium; RRt: relative retention time; VL: visceral
leishmaniasis..
Competing interests
The authors declare that they have no competing interests.
Yao and Wilson Parasites & Vectors  (2016) 9:200 Page 10 of 12
Authors’ contributions
CY conceived of the study, and participated in its design, and performed all
experiments and helped to draft the manuscript. MEW conceived of the
study, and helped to draft the manuscript. All authors read and approved
the final manuscript.
Acknowledgment
The authors are very grateful to Dr. Lynn M. Teesch of High Resolution Mass
Spectrometry Facility, University of Iowa for her help in analyzing sterols by
GC-MS. The cost of publication is paid by an intramural grant of One Health
Center for Zoonoses and Tropical Veterinary Medicine of Ross University
School of Veterinary Medicine. The work was funded in part by NIH grants
R01 AI076233 and R01 AI045540, and Merit Review grants 5I01BX001983 and
2I01BX000536 from the Department of Veterans’ Affairs.
Author details
1Department of Biomedical Sciences and One Health Center for Zoonoses
and Tropical Veterinary Medicine, Ross University School of Veterinary
Medicine, P.O. Box 334, Basseterre, St. Kitts, West Indies. 2Departments of
Internal Medicine, Microbiology and Epidemiology, University of Iowa, Iowa
City, IA USA. 3Iowa City VA Medical Center, Iowa City, IA USA.
Received: 4 December 2015 Accepted: 23 March 2016
References
1. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp
Immunol Microbiol Infect Dis. 2004;27(5):305–18.
2. Bates PA. Transmission of Leishmania metacyclic promastigotes by
phlebotomine sand flies. Int J Parasitol. 2007;37(10):1097–106.
3. Yao C, Chen Y, Sudan B, Donelson JE, Wilson ME. Leishmania chagasi:
Homogenous metacyclic promastigotes isolated by buoyant density are
highly virulent in a mouse model. Exp Parasitol. 2008;118:129–33.
4. Roberts CW, McLeod R, Rice DW, Ginger M, Chance ML, Goad LJ. Fatty acid
and sterol metabolism: potential antimicrobial targets in apicomplexan
and trypanosomatid parasitic protozoa. Mol Biochem Parasitol.
2003;126(2):129–42.
5. Goad LJ, Holz JGG, Beach DH. Sterols of Leishmania species, implications for
biosynthesis. Molecular & Biochemical Parasitology. 1984;10:161–70.
6. Denny PW, Field MC, Smith DF. GPI-anchored proteins and glycoconjugates
segregate into lipid rafts in Kinetoplastida. FEBS Lett. 2001;491(1-2):148–53.
7. Denny PW, Goulding D, Ferguson MA, Smith DF. Sphingolipid-free
Leishmania are defective in membrane trafficking, differentiation and
infectivity. Mol Microbiol. 2004;52(2):313–27.
8. Yao C, Gaur Dixit U, Barker JH, Teesch LM, Love-Homan L, Donelson JE,
Wilson ME. Attenuation of Leishmania infantum chagasi metacyclic
promastigotes by sterol depletion. Infect Immun. 2013;81(7):2507–17.
9. Mishra BB, Kale RR, Singh RK, Tiwari VK. Alkaloids: Future prospective to
combat leishmaniasis. Fitoterapia. 2009;80(2):81–90.
10. Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int
Health. 2001;6(11):849–54.
11. Durand R, Paul M, Pratlong F, Rivollet D, Dubreuil-Lemaire ML, Houin R,
Astier A, Deniau M. Leishmania infantum: lack of parasite resistance to
amphotericin B in a clinically resistant visceral leishmaniasis. Antimicrob
Agents Chemother. 1998;42(8):2141–3.
12. Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob Chemother.
2002;49 Suppl 1:7–10.
13. Xu W, Hsu FF, Baykal E, Huang J, Zhang K. Sterol biosynthesis is required for
heat resistance but not extracellular survival in Leishmania. PLoS Pathog.
2014;10(10):e1004427.
14. Roberts SC, Wilson ME, Donelson JE. Developmentally regulated expression
of a novel 59-kDa product of the major surface protease (Msp or gp63)
gene family of Leishmania chagasi. J Biol Chem. 1995;270(15):8884–92.
15. Yao C, Donelson JE, Wilson ME. Internal and surface-localized MSP of
Leishmania and their differential release from promastigotes. Eukaryot Cell.
2007;6(10):1905–12.
16. Cauchetier E, Loiseau PM, Lehman J, Rivollet D, Fleury J, Astier A, Deniau M,
Paul M. Characterisation of atovaquone resistance in Leishmania infantum
promastigotes. Int J Parasitol. 2002;32(8):1043–51.
17. Cosentino RO, Aguero F. Genetic profiling of the isoprenoid and sterol
biosynthesis pathway genes of Trypanosoma cruzi. PLoS One. 2014;9(5):e96762.
18. Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bartholomeu
DC, Lennard NJ, Caler E, Hamlin NE, Haas B Lennard NJ, Caler E, Hamlin NE,
Haas B et al. The genome of the African trypanosome Trypanosoma brucei.
Science. 2005;309(5733):416–22.
19. El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, Tran AN, Ghedin E,
Worthey EA, Delcher AL, Blandin G et al. The genome sequence of Trypanosoma
cruzi, etiologic agent of Chagas disease. Science. 2005;309(5733):409–15.
20. El-Sayed NM, Myler PJ, Blandin G, Berriman M, Crabtree J, Aggarwal G, Caler
E, Renauld H, Worthey EA, Hertz-Fowler C et al. Comparative genomics of
trypanosomatid parasitic protozoa. Science. 2005;309(5733):404–9.
21. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, Sisk
E, Rajandream MA, Adlem E, Aert R et al. The genome of the kinetoplastid
parasite, Leishmania major. Science. 2005;309(5733):436–42.
22. McCall L-I, El Aroussi A, Choi JY, Vieira DF, De Muylder G, Johnston JB, Chen
S, Kellar D, Siqueira-Neto JL, Roush WR et al. Targeting ergosterol
biosynthesis in Leishmania donovani: essentiality of sterol 14alpha-
demethylase. PLoS Negl Tropic Dis. 2015;9(3):e0003588.
23. Cota GF, de Sousa MR, de Mendonca AL, Patrocinio A, Assuncao LS, de Faria
SR, Rabello A. Leishmania-HIV co-infection: clinical presentation and
outcomes in an urban area in Brazil. PLoS Negl Tropic Dis. 2014;8(4):e2816.
24. Rakotomanga M, Blanc S, Gaudin K, Chaminade P, Loiseau PM. Miltefosine
affects lipid metabolism in Leishmania donovani promastigotes. Antimicrob
Agents Chemother. 2007;51(4):1425–30.
25. Lorente SO, Rodrigues JC, Jimenez Jimenez C, Joyce-Menekse M, Rodrigues
C, Croft SL, Yardley V, de Luca-Fradley K, Ruiz-Perez LM, Urbina J et al. Novel
azasterols as potential agents for treatment of leishmaniasis and
trypanosomiasis. Antimicrob Agents Chemother. 2004;48(8):2937–50.
26. Torres-Santos EC, Sampaio-Santos MI, Buckner FS, Yokoyama K, Gelb M,
Urbina JA, Urbina JA, Rossi-Bergmann B. Altered sterol profile induced in
Leishmania amazonensis by a natural dihydroxymethoxylated chalcone.
J Antimicrob Chemother. 2009;63(3):469–72.
27. Rakotomanga M, Saint-Pierre-Chazalet M, Loiseau PM. Alteration of fatty
acid and sterol metabolism in miltefosine-resistant Leishmania donovani
promastigotes and consequences for drug-membrane interactions.
Antimicrob Agents Chemother. 2005;49(7):2677–86.
28. de Souza W, Rodrigues JC. Sterol biosynthesis pathway as target for anti-
trypanosomatid drugs. Interdiscip Perspect Infect Dis. 2009;2009:642502.
29. Nes Craigen R, Singha Ujjal K, Liu J, Ganapathy K, Villalta F, Waterman
Michael R, Lepesheva Galina I, Chaudhuri M, Nes WD. Novel sterol
metabolic network of Trypanosoma brucei procyclic and bloodstream forms.
Biochem J. 2012;443(1):267–77.
30. Oehlschlager AC, Angus RH, Pierce AM, Pierce Jr HD, Srinivasan R. Azasterol
inhibition of delta 24-sterol methyltransferase in Saccharomyces cerevisiae.
Biochemistry. 1984;23(16):3582–9.
31. Osumi T, Taketani S, Katsuki H, Kuhara T, Matsumoto I. Ergosterol
biosynthesis in yeast. Pathways in the late stages and their variation under
various conditions. J Biochem. 1978;83(3):681–91.
32. Niedermeyer TH, Lindequist U, Mentel R, Gordes D, Schmidt E, Thurow K,
Lalk M. Antiviral terpenoid constituents of Ganoderma pfeifferi. J Nat Prod.
2005;68(12):1728–31.
33. Giner JL, Zhao H. Detailed sterol compositions of two pathogenic rust fungi.
Lipids. 2004;39(8):763–7.
34. Mahto KK, Singh A, Khandelwal NK, Bhardwaj N, Jha J, Prasad R. An assessment
of growth media enrichment on lipid metabolome and the concurrent
phenotypic properties of Candida albicans. PLoS One. 2014;9(11):1–20.
35. Acuna-Johnson AP, Oehlschlager AC, Pierce AM, Pierce Jr HD, Czyzewska EK.
Stereochemistry of yeast Δ24-sterol methyl transferase. Bioorg Med Chem.
1997;5(5):821–32.
36. Chapuis L, Malosse C, Corio-Costet MF. Sterol composition of the woody
plant pathogenic fungus Eutypa lata. Phytochemistry. 1996;42(6):1599–601.
37. Neelakandan AK, Chamala S, Valliyodan B, Nes WD, Nguyen HT. Metabolic
engineering of soybean affords improved phytosterol seed traits. Plant
Biotechnol J. 2012;10(1):12–9.
38. Flannery AR, Renberg RL, Andrews NW. Pathways of iron acquisition and
utilization in Leishmania. Curr Opin Microbiol. 2013;16(6):716–21.
39. Wilson ME, Lewis TS, Miller MA, McCormick ML, Britigan BE. Leishmania
chagasi: uptake of iron bound to lactoferrin or transferrin requires an iron
reductase. Exp Parasitol. 2002;100(3):196–207.
40. Wilson ME, Vorhies RW, Andersen KA, Britigan BE. Acquisition of iron from
transferrin and lactoferrin by the protozoan Leishmania chagasi. Infect
Immun. 1994;62(8):3262–9.
Yao and Wilson Parasites & Vectors  (2016) 9:200 Page 11 of 12
41. da Silva IA, Morato CI, Quixabeira VBL, Pereira LIA, Dorta ML, de Oliveira
MAP, et al. In Vitro Metacyclogenesis of Leishmania (Viannia) braziliensis
and Leishmania (Leishmania) amazonensis clinical field isolates, as evaluated
by morphology, complement resistance, and infectivity to human
macrophages. Bio Med Res Int. 2015;2015:15.
42. Saraiva EM, Pinto-da-Silva LH, Wanderley JL, Bonomo AC, Barcinski MA,
Moreira ME. Flow cytometric assessment of Leishmania spp. metacyclic
differentiation: Validation by morphological features and specific markers.
Exp Parasitol. 2005;110(1):39–47.
43. Bandyopadhyay P, Ghosh DK, De A, Ghosh KN, Chaudhuri PP, Das P, et al.
Metacyclogenesis of Leishmania spp.: species-specific in vitro transformation,
complement resistance, and cell surface carbohydrate and protein profiles.
J Parasitol. 1991;77(3):411–6.
44. Howard MK, Sayers G, Miles MA. Leishmania donovani metacyclic
promastigotes: transformation in vitro, lectin agglutination, complement
resistance, and infectivity. Exp Parasitol. 1987;64(2):147–56.
45. Nieves E, Pimenta PF. Development of Leishmania (Viannia) braziliensis and
Leishmania (Leishmania) amazonensis in the sand fly Lutzomyia migonei
(Diptera: Psychodidae). J Med Entomol. 2000;37(1):134–40.
46. Pinto-da-Silva LH, Camurate M, Costa KA, Oliveira SM, da Cunha-e-Silva NL,
Saraiva EM. Leishmania (Viannia) braziliensis metacyclic promastigotes
purified using Bauhinia purpurea lectin are complement resistant and highly
infective for macrophages in vitro and hamsters in vivo. Int J Parasitol.
2002;32(11):1371–7.
47. Sturley SL. Conservation of eukaryotic sterol homeostasis: new insights from
studies in budding yeast. Biochim Biophys Acta. 2000;1529(1-3):155–63.
48. Jacquier N, Schneiter R. Mechanisms of sterol uptake and transport in yeast.
J Steroid Biochem Mol Biol. 2012;129(1-2):70–8.
49. Bates PA, Tetley L. Leishmania mexicana: induction of metacyclogenesis by
cultivation of promastigotes at acidic pH. Exp Parasitol. 1993;76(4):412–23.
50. Serafim TD, Figueiredo AB, Costa PAC, Marques-da-Silva EA, Gonçalves R, de
Moura SAL, et al. Leishmania metacyclogenesis is promoted in the absence
of purines. PLoS Negl Trop Dis. 2012;6(9):e1833.
51. Zakai HA, Chance ML, Bates PA. In vitro stimulation of metacyclogenesis in
Leishmania braziliensis, L. donovani, L. major and L. mexicana. Parasitology.
1998;116(Pt 4):305–9.
52. Goluszko P, Nowicki B. Membrane cholesterol: a crucial molecule affecting
interactions of microbial pathogens with mammalian cells. Infect Immun.
2005;73(12):7791–6.
53. Ghosh J, Das S, Guha R, Ghosh D, Naskar K, Das A, et al. Hyperlipidemia
offers protection against Leishmania donovani infection: role of membrane
cholesterol. J Lipid Res. 2012;53(12):2560–72.
54. Liberopoulos EN, Apostolou F, Gazi IF, Kostara C, Bairaktari ET, Tselepis AD,
et al. Visceral leishmaniasis is associated with marked changes in serum lipid
profile. Eur J Clin Invest. 2014;44(8):719–27.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Yao and Wilson Parasites & Vectors  (2016) 9:200 Page 12 of 12
